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Abstract: 
Objectives: A recent study described increased L-lactate concentrations in ponies with 
gastrointestinal disease compared to horses, but blood glucose (BG) concentrations were not 
considered. The study tested the hypothesis that BG and L-lactate concentrations are correlated 
in horses and ponies with gastrointestinal disease and that BG concentrations, not equid type 
(pony vs horse), are an independent predictor of L-lactate concentrations. It was further 
hypothesized that equid type was an independent predictor of BG concentrations. 
Design: Retrospective study 2008-2016 
Setting: University teaching hospital 
Animals: Admission data from 545 animals (384 horses and 161 ponies) with gastrointestinal 
disease.  
Interventions: Data collected included signalment, clinicopathological findings on admission 
and nature and location of the gastrointestinal lesion (strangulating vs non-strangulating and 
large vs small intestinal lesion). The association between admission blood L-lactate 
concentrations, equid type (pony or horse) and BG concentrations was investigated in a 
multivariable model. 
Measurements and Main Results: Admission L-lactate and BG concentrations were strongly 
correlated (n=522; r=0.63; p<0.001). Ponies had significantly higher L-lactate (2.7mmol/L 
(0.5-18.0mmol/L) versus 1.4mmol/L (0.3-19mmol/L); p<0.001) and BG concentrations than 
horses (8.4mmol/L (4.2-24.4mmol/L); 151mg/dL (76-439mg/dL) versus 6.9mmol/L (3.4-
26.8mmol/L); 124mg/dL (61-482mg/dL); p<0.001). In the multivariable analysis, L-lactate 
concentrations were significantly and positively associated with admission BG concentrations 
in all animals and also with equid type. For each mmol/L (18mg/dL) increase in BG, L-lactate 
concentrations increased by 7.9% (5.9, 9.9); p<0.001. In comparison to ponies, L-lactate 
concentrations were decreased by 27.7% (37.4, 16.5); p<0.001 in horses. Admission BG 
concentrations were significantly and positively associated with L-lactate concentrations in all 
animals. For each mmol/L increase in L-lactate concentration, BG concentration increased by 
6.2% (4.7, 7.6; p<0.001). Admission BG concentrations were not associated with equid type. 
Conclusion: Admission BG concentrations and equid type are independent predictors of blood 








Hyperglycemia and hyperlactatemia are common findings in human patients admitted to 
emergency departments1. Initial studies indicated that BG concentrations are an independent 
risk factor for morbidity and mortality2-4. However, the direct relationship between BG and 
mortality has been questioned, particularly as L-lactate concentrations were not taken into 
consideration in the aforementioned studies5, 6. Indeed, two subsequent investigations found 
that hyperlactatemia significantly influenced the relationship between BG and mortality7, 8. 
Both studies demonstrated that an independent relationship between hyperglycemia and 
mortality no longer existed once L-lactate concentrations were considered7, 8. The authors 
concluded that L-lactate concentrations are directly associated with BG concentrations and 
mortality, and that a direct association between BG concentrations and mortality did not exist. 
In earlier studies in people, it is likely that a direct association was wrongly assumed due to the 
omission of L-lactate from statistical analyses. These findings highlight the importance of 
including both parameters, BG and L-lactate concentrations, in clinical investigations as 
alterations in one will affect the other. Omission of one parameter could lead to erroneous 
conclusions, as demonstrated in the investigations into the association between BG 
concentrations and outcome in people7, 8.  
 
A recent study in equids documented higher L-lactate concentrations in ponies with 
gastrointestinal disease when compared to large breed horses with a similar disease severity9. 
Reasons for the differences in L-lactate concentrations were not immediately apparent but BG 
concentrations were not included in the analysis. Differences in insulin sensitivity and BG 
concentrations between ponies and horses have long been identified. Normal ponies respond 
with higher BG and insulin concentrations to an oral glucose tolerance test compared to large 
breed horses, suggesting a degree of insulin resistance in ponies. These differences are 
exacerbated in obese and laminitic ponies10. It is conceivable that the previously identified 
differences in L-lactate concentrations between horses and ponies were indeed secondary to 
differences in BG concentrations and not equid type (horse versus pony). As BG concentrations 
were not included, this relationship may not have been uncovered and a direct association 
between L-lactate and equid type was assumed. 
 
The current study tested the hypothesis that admission BG and L-lactate concentrations are 
correlated in horses and ponies with gastrointestinal disease and that BG concentrations, not 
equid type (pony vs horse), are an independent predictor of L-lactate concentrations. It was 




Materials and Methods: 
Medical records from September 2008 to April 2016 were reviewed retrospectively for any 
horse or pony presenting to The Royal Veterinary College Equine Referral Hospital with a 
primary complaint of gastrointestinal disease in which BG and/or L-lactate had been measured 
on admission. Some of the animals had been included in an earlier study9. Data extracted from 
the medical records included duration of clinical signs, clinicopathological findings on 
admission and location (small vs large intestine) and nature (strangulating vs non-
strangulating) of the intestinal lesion. Equids were classified as pony type by breed and/or 
height. In animals with absent or ambiguous breed recordings (for example “pony”, “Cob”, 
“pony cross”, “crossbreed”) only animals ≤14 hands (classified as pony type) and ≥15 hands 
(classified as horse type) were included to avoid misclassification. 
 
Jugular venous blood samples were collected on admission in 2.5ml heparinised syringes 
(Arterial Blood Sampler)a and in-house blood gas analysis and L-lactate, electrolyte, blood 
glucose and creatinine measurements were carried out on whole blood immediately following 
collection using a commercial analyser (Stat Profile® Critical Care Xpress)b. Other 
clinicopathological data collected included packed cell volume (PCV), total plasma solid 
concentration (TS) and results of peritoneal fluid analysis (protein concentration and nucleated 
cell count). Protein concentrations in plasma and peritoneal fluid were measured using a hand-
held refractometer while nucleated cell counts on blood and peritoneal fluid were performed 
using an automated analyserc.  
 
Cases were excluded if disease was found to be other than gastrointestinal in origin. Animals 
<1 year of age and donkeys were also excluded. 
 
Statistical analysis 
Data were analyzed using a commercially available software programmed. Continuous data are 
expressed as mean ± standard deviation (if normally distributed) or median and range 
(minimum to maximum) and categorical data are presented as numbers and percentages. 
Normality of the data was assessed using the Shapiro-Wilk test and comparisons between 
ponies and horses were made using a Mann Whitney U test (all continuous data were not 
normally distributed). Chi-squared test was used to compare categorical measurements 
between the two groups.   
 
The relationship between admission BG and L-lactate concentrations was evaluated using 
bivariate Spearman’s correlation (r).  
 
To achieve a normal distribution for the association analysis, admission blood L-lactate and 
BG concentrations were log10 transformed (logLact and logBG). Since BG and L-lactate 
concentrations are interconnected metabolites in the carbohydrate metabolism and each can 
lead to the generation of the other, two separated linear models were used to investigate their 
association where logLact or logBG was each in turn used as response variable and the other 
as a predictor. Equid type (pony vs horse) and other confounding variables were also assessed 
in both models. All confounding variables with a p-value <0.1 in the univariable analysis were 
assessed in the multivariable analysis, and manual backward elimination procedure was 
adopted to obtain the final multivariable model.  
 
Results of the final linear models were displayed as regression coefficient ± standard error. 
Since the response was log10 transformed, its expected change in the original scale and 95% 
confidence interval were also presented.   
 
Statistical significance was set at p≤0.05 for all analyses. 
 
Results: 
Five hundred and forty five animals (384 horses and 161 ponies) were included in the study, 
comprised of 224 mares, 302 geldings and 19 stallions with a median age of 12 years (range 1-
33 years). Horse types consisted of Thoroughbreds and Thoroughbred crosses (n=94), 
Warmbloods and Warmblood crosses (n=86), Irish Sport and Irish Draft horses (n=62), Cobs 
(n=42), Arabians and Arabian crosses (n=17), other Draft breeds (n=15), Andalusians (n=5), 
Frisians (n=5) and a number of horses from other breeds (n=57). Pony types were comprised 
of Welsh ponies (n=45), native pony breeds (n=39), Shetland ponies (n=24), Connemaras (n=9) 
miniature breeds (n=5) and a number of ponies from other breeds (n=39). Table 1 summarizes 
clinicopathological findings and details of intestinal lesions divided by horse and pony types; 
differences in height were pre-determined by definition of “horse” and “pony”. 
 
Inspection of scatterplots and Spearman’s correlation indicated a strong positive relationship 
between BG and L-lactate concentrations in all animals (Figure 1; n=522; r=0.63; p<0.001) 
and in ponies (n=154; r=0.52; p<0.001) and horses (n=368; r=0.66; p<0.001) when analysed 
separately. 
 
LogLact was significantly associated with equid type in a univariable model (p<0.001). Factors 
included in the multivariable model (p<0.1) were equid type, HR, RR, T, PCV, TS, peritoneal 
protein, creatinine and BG concentrations, reflux volume and location (small or large intestine) 
and nature (strangulating or non-strangulating) of the intestinal lesion. Sex, age, duration of 
clinical signs prior to admission and peritoneal WBC were not included (p>0.1). In the final 
multivariable analysis, equid type, admission BG concentration, HR, PCV, T and nature of the 
lesion were all significantly associated with logLact (Table 2). For each mmol/L (18mg/dL) 
increase in BG, L-lactate concentration increased by 7.9%; p<0.001. 
 
LogBG was significantly different between equid types in the univariable model (p<0.001). 
Factors assessed in the multivariable model (p<0.1) were equid type, age, HR, RR, PCV, 
peritoneal protein and nucleated cell count and creatinine concentration, reflux volume and 
location (small or large intestine) and nature (strangulating/non-strangulating) of the intestinal 
lesion. Sex, duration of clinical signs prior to admission, temperature and TS were not included 
(p>0.1). In the final multivariable model, only blood L-lactate, peritoneal protein 
concentration, HR and lesion location (small versus large intestine) were significantly 
associated with logBG (Table 3); equid type was not significantly associated (p=0.065). For 




As demonstrated in investigations in people, a strong positive correlation between blood L-
lactate and glucose concentrations was also detected in horses and ponies with gastrointestinal 
disease. This finding confirms the importance of analysing both parameters together as 
alterations in one may strongly influence the other. Against the proposed hypothesis, results of 
this study concurred with those of a previous study that equid type did significantly influence 
blood L-lactate concentrations. This association was independent of BG concentrations, 
although BG concentrations were also significantly associated with L-lactate concentrations. 
As the close correlation between the two parameters highlights, BG and L-lactate 
concentrations are interconnected metabolites in the carbohydrate metabolism and each can 
lead to the generation of the other11, 12. Anaerobic glycolysis of glucose generates L-lactate as 
an end product while L-lactate, via generation of pyruvate, can initiate gluconeogenesis or 
glycogen formation13. In septic human patients, 45% of L-lactate is converted into glucose 
either by gluconeogenesis or glycogen production14. It is therefore conceivable that increased 
L-lactate concentrations, at least partially, contribute to the increased BG observed in critically 
ill equids. In equids with gastrointestinal disease and human patients with sepsis or septic 
shock, increased blood L-lactate concentrations are commonly viewed as markers of tissue 
hypoxia, presumed to be secondary to hypoperfusion15, 16. At least in critically ill people, this 
view is currently changing and some investigators have suggested that increased aerobic 
glycolysis secondary to adrenergic stimulation plays a large, if not the largest, role in the 
development of hyperlactatemia15, 17. It is assumed that the underlying mechanism involves 
stimulation of muscle glycogenolysis through ß-adrenergic activation of glycogen 
phosphorylase activity to provide quickly available energy substrates18. Interestingly, a strong 
positive association between plasma adrenalin and L-lactate concentrations has also been 
identified in horses with colic19. Other reasons for increased L-lactate concentrations include 
decreased clearance due to organ dysfunction, the nature of an underlying disease process, 
presence of drugs or toxins that alter the metabolism or inborn errors of metabolism20. The 
exact source of increased L-lactate concentrations in critically ill equids therefore requires 
further investigations to confirm or refute the use of L-lactate largely as a marker of tissue 
hypoxia. 
 
The underlying reason for higher L-lactate concentrations in ponies compared to horses is still 
unknown. In people, increases in L-lactate concentrations are closely associated with fasting 
glucose and insulin concentrations, insulin resistance and type 2 diabetes21-24. Increases in L-
lactate concentration are predictive of development of insulin resistance and might be an 
independent risk factor for the development of type 2 diabetes25, 26. In a mouse model, increased 
L-lactate production by adipose and muscle tissue was thought to be at least partially 
responsible for insulin resistance and diabetes25. The origin of the increased L-lactate 
concentrations in people is still unknown but a decreased aerobic capacity has been 
suggested27. A low oxidative capacity due to impaired mitochondrial phosphorylation has been 
associated with subclinical or clinical insulin resistance23. Although it is currently unknown 
whether the low oxidative capacity is a consequence or cause of insulin resistance, recent 
studies have suggested that a low oxidative capacity may precede insulin resistance and 
diabetes28, 29. It is possible that an underlying lower oxidative capacity could contribute to the 
observed differences in L-lactate, glucose and insulin metabolism between ponies and horses9, 
10. Another possibility are differences in the metabolic response under sympathetic stimulation. 
In people, adrenalin directly increases lipolysis and L-lactate release from leg tissue18 and a 
similar lipolytic effect after adrenergic stimulation has been observed in horses and ponies30. 
However, in contrast to horse adipocytes, pony adipocytes release free fatty acid in an 
accelerated linear fashion in response to norepinephrine, which is thought to contribute to the 
predisposition of hyperlipemia in ponies31. It is possible that similar differences in the 
sympathetic regulation of glucose and L-lactate metabolism exist between horses and ponies, 
causing tissues in ponies to release L-lactate more rapidly or in larger quantities. Further studies 
are necessary to investigate these possibilities.  
 
Blood L-lactate concentrations were also significantly associated with lesion nature 
(strangulating vs non-strangulating), as previously reported in other studies32. Concentrations 
were lower in animals with non-strangulating lesions, supporting the assumption that high L-
lactate concentrations in animals admitted for colic are often associated with the presence of a 
strangulating lesion. 
 
Surprisingly, and against the study hypothesis, equid type had no significant influence on BG 
concentrations. This was an unexpected finding as previous investigations have suggested 
differences in insulin sensitivity and BG concentrations between ponies and horses with ponies 
showing a degree of insulin resistance10, 33, 34.  Altered insulin sensitivity has also been 
documented in certain horse breeds, particularly Andalusians, who (like ponies) exhibit insulin 
resistance, and it is possible that further differences exist, with some horse and pony breeds 
being more, or less, insulin sensitive than others33, 34. Whether these differences are the result 
of an early disease process or simply represent metabolic differences is currently unknown. 
Inspection of horse breeds included in this study identified 5 Andalusians but exclusion of these 
did not alter the results significantly. It is possible that inclusion of more animals would have 
identified a significant association as the p-value was bordering on significance (p=0.064). On 
the other hand, differences in glucose metabolism associated with equid type may be no longer 
be apparent once the animal is exposed to the stresses of gastrointestinal disease. The 
association with other parameters closely linked to disease severity such as heart rate and 
peritoneal protein concentration suggests this might be the case. Blood L-lactate concentrations 
were also an important predictor of blood glucose concentrations, as one would expect based 
on the close correlation. 
 
Admission BG concentrations were also correlated with lesion location, being higher in 
animals with small intestinal lesions compared to those with large intestinal lesions. It is 
possible that small intestinal lesions were associated with more intense pain and cardiovascular 
disturbances, contributing to higher admission BG concentrations in this group. 
 
In summary, admission BG concentrations and equid type were significantly correlated with 
admission blood L-lactate concentrations in animals with gastrointestinal disease. However, 
equid type, even though an independent predictor of L-lactate, was not significantly associated 
with blood glucose concentrations in equids in this study. The relationship between BG and L-
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Figure 1: Scatter plot showing correlation between admission blood L-lactate (x-axis) and 
glucose (y-axis) concentrations from 522 horses and ponies with gastro-intestinal disease. 
 
Table 1: Comparison between clinicopathological findings and intestinal lesion location and 
nature between horses and ponies. Data are displayed as median (range) §: based on χ2 test; all 
other comparisons were carried out using a Mann-Whitney U test. A p-value of ≤ 0.05 was 
considered significant. 
 
Table 2: Results of a general linear model investigating the association between log-
transformed blood L-lactate concentrations (dependent variable), equid type (pony vs horse) 
and confounding variables. Lesion nature refers to strangulating or non-strangulating intestinal 
lesions. SE: standard error; a p-value of ≤ 0.05 was considered significant. 
 
 
Table 3: Results of a general linear model investigating the association between log-
transformed blood glucose concentrations (dependent variable), equid type (pony vs horse) and 
confounding variables. Lesion location refers to small or large intestinal lesions. SE: standard 








 Horse Pony p-
value 
Age 12 (1-31) n=382 13 (1-33) n=160 0.4 
Height (cm) 165 (152-188) n=340 135 (71-147) n=139 <0.001 
Weight (kg) 553 (334-879) n=365 350 (57-580) n=154 <0.001 
Duration of signs (h) 7 (1-240) n=326 8 (1-332) n=139 0.06 
Heart rate (bpm) 48 (28-130) n=375 58 (30-120) n=160 <0.001 
Respiratory rate (bpm) 20 (6-92) n=366 20 (8-88) n=158 0.002 
Rectal temperature (°C) 37.7 (34-39.6) n=336 37.8 (35-39.9) 
n=146 
0.12 
Packed cell volume (%) 39 (23-80) n=377 39 (24-70) n=158 0. 95 
Total plasma solids concentration 
(g/L and g/dL) 
66 (36-108) n=374 
6.6 (3.6-10.8) 
68 (37-110) n=155 
6.8 (3.7-11) 
0.12 
L-lactate concentration (mmol/L) 1.4 (0.3-19) n=367 2.7 (0.5-18.0) 
n=155 
<0.001 
Creatinine concentration (µmol/L 
and mg/dL) 
121 (73-1445) n=307 
1.4 (0.8-16.3) 
111 (50-633) n=120 
111 (0.6-7.2) 
0.35 
Blood glucose concentration 
(mmol/L) 






Peritoneal protein concentration 
(g/L and g/dL) 
15 (0.4-99) n=257 
1.5 (0-9.9) 
22 (2-58) n=104 
2.2 (0.2-5.8) 
0.023 
Reflux (L) 0 (0-22) n=335 0 (0-12) n=149 0.85 
 
Small intestinal lesion 129 81 0.003§ 
Large intestinal lesion 244 77 
 
Non-strangulating lesion 269 107 0.52§ 
Strangulating lesion 115 54 
 
  
Table 2:  
Variable Regression Coefficient 
± SE (log scale) 




Equid type (pony 
reference) 




-0.116±0.033 -23.4 (-34.1, -11.1) 0.001 
Heart rate 0.005±0.001 1.2 (0.7, 1.6) <0.001 
Temperature 0.042±0.02 10.2 (0.6, 20.6) 0.036 
Packed cell volume 0.007±0.002 1.6 (0.7, 2.5) <0.001 
Blood glucose 
concentration 
0.033±0.004 7.9 (5.9, 9.9) <0.001 
 
  
Table 3:  
Variable Regression 
Coefficient ± SE 




Lesion location (large 
intestine reference) 
0.045±0.018 10.9 (2.3, 20.3) 0.014 
Heart rate 0.001±0.0001 0.2 (0.1, 0.7) 0.045 
L-Lactate concentration 0.026±0.003 6.2 (4.7, 7.6) <0.001 
Peritoneal protein 0.003±0.001 0.7 (0.2, 1.1) <0.001 
 
 
